Boxer Capital, LLC
- SEC CIK
- 0001465837
- Latest filing
- Feb 14, 2025
Holdings in Q2 2023
Holdings as of Jun 30, 2023, filed Aug 14, 2023. Long positions only; changes compare share counts with Q1 2023.
- Positions
- 79
- +4 vs. Q1 2023
- Portfolio value
- $2.16B
- +$120.6M (+5.9%) vs. Q1 2023
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| RETAReata Pharmaceuticals Inc | CL A | 1,430,004 | $145.8M | 6.8% | +200,000+16.3% | Added | History |
| APLSApellis Pharmaceuticals, Inc. | COM | 1,576,000 | $143.6M | 6.7% | 00.0% | Unchanged | History |
| RVMDRevolution Medicines, Inc. | COM | 4,684,264 | $125.3M | 5.8% | 00.0% | Unchanged | History |
| TYRATyra Biosciences, Inc. | COM | 6,448,359 | $109.8M | 5.1% | 00.0% | Unchanged | History |
| SWTXSpringWorks Therapeutics, Inc. | COM | 3,421,541 | $89.7M | 4.2% | 00.0% | Unchanged | History |
| ONCBeOne Medicines Ltd. | ADR | 500,000 | $89.2M | 4.1% | 00.0% | Unchanged | History |
| AKROAkero Therapeutics, Inc. | COM | 1,676,733 | $78.3M | 3.6% | +845,238+101.7% | Added | History |
| MRTXMirati Therapeutics, Inc. | COM | 2,000,000 | $72.3M | 3.4% | 00.0% | Unchanged | History |
| SRPTSarepta Therapeutics, Inc. | COM | 600,000 | $68.7M | 3.2% | −175,000−22.6% | Reduced | History |
| CYTKCytokinetics Inc | COM NEW | 2,100,000 | $68.5M | 3.2% | 00.0% | Unchanged | History |
| IMGNImmunoGen, Inc. | COM | 2,961,000 | $55.9M | 2.6% | +2,961,000 | New | History |
| KRTXKaruna Therapeutics, Inc. | COM | 250,000 | $54.2M | 2.5% | +250,000 | New | History |
| IDYAIDEAYA Biosciences, Inc. | COM | 2,202,812 | $51.8M | 2.4% | 00.0% | Unchanged | History |
| SAGESage Therapeutics, Inc. | COM | 1,094,000 | $51.4M | 2.4% | 00.0% | Unchanged | History |
| NUVLNuvalent, Inc. | COM | 1,210,192 | $51.0M | 2.4% | 00.0% | Unchanged | History |
| MRUSMerus N.V. | COM | 1,900,000 | $50.0M | 2.3% | 00.0% | Unchanged | History |
| AMLXAmylyx Pharmaceuticals, Inc. | COM | 2,084,000 | $45.0M | 2.1% | 00.0% | Unchanged | History |
| LEGNLegend Biotech Corp | SPONSORED ADS | 600,000 | $41.4M | 1.9% | +600,000 | New | History |
| ETNB89bio, Inc. | COM | 2,100,000 | $39.8M | 1.8% | 00.0% | Unchanged | History |
| RCUSArcus Biosciences, Inc. | COM | 1,602,200 | $32.5M | 1.5% | +170,000+11.9% | Added | History |
| ISEEIVERIC bio, Inc. | COM | 825,000 | $32.5M | 1.5% | 00.0% | Unchanged | History |
| VKTXViking Therapeutics, Inc. | COM | 2,000,000 | $32.4M | 1.5% | 00.0% | Unchanged | History |
| ARGXArgenx SE | SPONSORED ADR | 75,000 | $29.2M | 1.4% | +75,000 | New | History |
| FOLDAmicus Therapeutics, Inc. | COM | 2,325,000 | $29.2M | 1.4% | 00.0% | Unchanged | History |
| RCKTRocket Pharmaceuticals, Inc. | COM | 1,466,051 | $29.1M | 1.4% | 00.0% | Unchanged | History |
| AXSMAxsome Therapeutics, Inc. | COM | 400,000 | $28.7M | 1.3% | 00.0% | Unchanged | History |
| ITOSiTeos Therapeutics, Inc. | COM | 2,154,058 | $28.5M | 1.3% | 00.0% | Unchanged | History |
| VTYXVentyx Biosciences, Inc. | COM | 850,000 | $27.9M | 1.3% | 00.0% | Unchanged | History |
| ANABAnaptysbio, Inc | COM | 1,300,000 | $26.4M | 1.2% | 00.0% | Unchanged | History |
| IOVAIovance Biotherapeutics, Inc. | COM | 3,705,133 | $26.1M | 1.2% | 00.0% | Unchanged | History |
| TNGXTango Therapeutics, Inc. | COM | 7,123,642 | $23.6M | 1.1% | 00.0% | Unchanged | History |
| MDGLMadrigal Pharmaceuticals, Inc. | COM | 100,000 | $23.1M | 1.1% | +100,000 | New | History |
| XENEXenon Pharmaceuticals Inc. | COM | 600,000 | $23.1M | 1.1% | 00.0% | Unchanged | History |
| RLAYRelay Therapeutics, Inc. | COM | 1,819,132 | $22.8M | 1.1% | −350,000−16.1% | Reduced | History |
| PNTPOINT Biopharma Global Inc. | COM | 2,500,000 | $22.6M | 1.1% | 00.0% | Unchanged | History |
| EXELExelixis, Inc. | COM | 1,150,000 | $22.0M | 1.0% | 00.0% | Unchanged | History |
| PRTAProthena Corp Public Ltd Co | SHS | 300,000 | $20.5M | 0.9% | 00.0% | Unchanged | History |
| PMVPPMV Pharmaceuticals, Inc. | COM | 3,163,795 | $19.8M | 0.9% | 00.0% | Unchanged | History |
| KALVKalVista Pharmaceuticals, Inc. | COM | 1,650,000 | $14.8M | 0.7% | 00.0% | Unchanged | History |
| ELVNEnliven Therapeutics, Inc. | COM | 710,644 | $14.5M | 0.7% | 00.0% | Unchanged | History |
| DAWNDay One Biopharmaceuticals, Inc. | Stock | 1,189,943 | $14.2M | 0.7% | 00.0% | Unchanged | History |
| ORICOric Pharmaceuticals, Inc. | COM | 1,732,571 | $13.4M | 0.6% | +678,571+64.4% | Added | History |
| ZNTLZentalis Pharmaceuticals, Inc. | COM | 450,000 | $12.7M | 0.6% | +450,000 | New | History |
| Avidity Biosciences, Inc.05370A108 | COM | 1,121,327 | $12.4M | 0.6% | 00.0% | Unchanged | – |
| NRIXNurix Therapeutics, Inc. | COM | 1,224,892 | $12.2M | 0.6% | 00.0% | Unchanged | History |
| CGEMCullinan Therapeutics, Inc. | COM | 1,074,082 | $11.6M | 0.5% | 00.0% | Unchanged | History |
| PRLDPrelude Therapeutics Inc | COM | 2,495,018 | $11.2M | 0.5% | +1,795,971+256.9% | Added | History |
| BDTXBlack Diamond Therapeutics, Inc. | COM | 2,014,858 | $10.2M | 0.5% | 00.0% | Unchanged | History |
| GERNGeron Corp | COM | 3,000,000 | $9.63M | 0.4% | +3,000,000 | New | History |
| ASNDAscendis Pharma A/S | SPONSORED ADR | 95,000 | $8.48M | 0.4% | 00.0% | Unchanged | History |
| CNTACentessa Pharmaceuticals plc | SPONSORED ADS | 1,251,137 | $7.75M | 0.4% | 00.0% | Unchanged | History |
| CABACabaletta Bio, Inc. | COM | 540,000 | $6.97M | 0.3% | 00.0% | Unchanged | History |
| COGTCogent Biosciences, Inc. | COM | 525,000 | $6.22M | 0.3% | 00.0% | Unchanged | History |
| IRONDisc Medicine, Inc. | COM | 130,000 | $5.77M | 0.3% | 00.0% | Unchanged | History |
| RAPTRAPT Therapeutics, Inc. | COM | 300,000 | $5.61M | 0.3% | 00.0% | Unchanged | History |
| TSVT2seventy bio, Inc. | COMMON STOCK | 459,836 | $4.65M | 0.2% | 00.0% | Unchanged | History |
| GOSSGossamer Bio, Inc. | COM | 3,336,928 | $4.00M | 0.2% | 00.0% | Unchanged | History |
| RNACCartesian Therapeutics, Inc. | COM | 3,284,072 | $3.68M | 0.2% | 00.0% | Unchanged | History |
| MRSNMersana Therapeutics, Inc. | COM | 1,000,000 | $3.29M | 0.2% | +1,000,000 | New | History |
| THRXTheseus Pharmaceuticals, Inc. | COM | 350,000 | $3.27M | 0.2% | 00.0% | Unchanged | History |
| MREOMereo BioPharma Group plc | SPON ADS | 2,250,000 | $2.97M | 0.1% | 00.0% | Unchanged | History |
| DBVTDBV Technologies S.A. | SPONSORED ADR | 1,450,000 | $2.75M | 0.1% | 00.0% | Unchanged | History |
| THRDThird Harmonic Bio, Inc. | COM | 570,417 | $2.74M | 0.1% | 00.0% | Unchanged | History |
| FATEFate Therapeutics Inc | COM | 500,000 | $2.38M | 0.1% | 00.0% | Unchanged | History |
| BCELAtreca, Inc. | CL A COM | 2,202,333 | $2.16M | 0.1% | 00.0% | Unchanged | History |
| BCABBioAtla, Inc. | COM | 686,347 | $2.06M | 0.1% | 00.0% | Unchanged | History |
| MISTMilestone Pharmaceuticals Inc. | COM | 698,861 | $1.99M | 0.1% | 00.0% | Unchanged | History |
| EQRXEQRx, Inc. | COM | 1,000,000 | $1.86M | 0.1% | 00.0% | Unchanged | History |
| OBIOOrchestra BioMed Holdings, Inc. | COM | 250,000 | $1.75M | 0.1% | 00.0% | Unchanged | History |
| KNTEKinnate Biopharma Inc. | COM | 491,000 | $1.49M | 0.1% | −19,000−3.7% | Reduced | History |
| Rain Oncology Inc.75082Q105 | COM | 1,152,212 | $1.38M | 0.1% | −995,000−46.3% | Reduced | – |
| NGMNGM Biopharmaceuticals Inc | COM | 500,000 | $1.29M | 0.1% | 00.0% | Unchanged | History |
| LITSLite Strategy, Inc. | COM NEW | 145,654 | $958.0K | <0.1% | 00.0% | UnchangedConverted for a 1-for-20 split | History |
| TCRTAlaunos Therapeutics, Inc. | COM | 1,500,000 | $765.0K | <0.1% | 00.0% | Unchanged | History |
| TARAProtara Therapeutics, Inc. | COM STK | 209,227 | $500.0K | <0.1% | 00.0% | Unchanged | History |
| VERUVeru Inc. | COM | 347,300 | $413.0K | <0.1% | 00.0% | Unchanged | History |
| Bellicum Pharmaceuticals, Inc079481404 | COM NEW | 450,000 | $167.0K | <0.1% | +450,000 | New | – |
| Nuvation Bio Inc.67080N119 | *W EXP 07/07/202 | 266,666 | $44.0K | <0.1% | 00.0% | Unchanged | – |
| Surrozen, Inc.86889P117 | *W EXP 08/01/203 | 66,666 | $4.00K | <0.1% | 00.0% | Unchanged | – |
Sold out since Q1 2023 (5)
Positions held at the end of Q1 2023 that are gone from this filing.
| Security | Class | Shares in Q1 2023 | Value in Q1 2023 | % of portfolio in Q1 2023 | History |
|---|---|---|---|---|---|
| RXDXPrometheus Biosciences, Inc. | COM | 1,897,500 | $203.6M | 10.0% | History |
| SGENSeagen Inc. | COM | 200,000 | $40.5M | 2.0% | History |
| Bellus Health Inc New07987C204 | COM NEW | 3,200,000 | $23.0M | 1.1% | – |
| MORFMorphic Holding, Inc. | COM | 200,000 | $7.53M | 0.4% | History |
| Panacea Acquisition Corp. IIG6882C106 | CL A SHS | 500,000 | $5.11M | 0.3% | – |